At a glance

Last updated: 31 August 2026. This page explains how to interpret PRO QUANT TRADE research and the risks that remain after statistical validation.

  • Public material is general and impersonal research for professional evaluation. It is not personalized investment, legal, tax, accounting, or regulatory advice; not a recommendation; and not an offer or solicitation.
  • A model, backtest, simulation, scenario, forecast, target, or paper-trading result is not live client performance. If verified actual performance is ever presented, it must be identified expressly and given its own basis, period, account, fee, and risk context.
  • Statistical significance is not the same as economic persistence, investability, capacity, suitability, or portfolio benefit.
  • Every reader remains responsible for independent diligence, professional advice, implementation controls, and investment decisions.
  • An article-specific disclosure must accompany material evidence. This site-wide page cannot cure an incomplete or misleading result presentation.

1. Scope of the publication

PRO QUANT TRADE publishes quantitative hypotheses, validation work, portfolio-fit analysis, research engineering, and related commentary. The work is intended to make an idea inspectable: what mechanism is proposed, what data and assumptions were used, what failed, what remains uncertain, and what evidence would change the conclusion.

Publication does not mean that an idea is approved, investable, suitable, available for licensing, or being traded. Reading, downloading, citing, or discussing research does not create an advisory, fiduciary, broker, dealer, commodity, client, employment, partnership, or agency relationship. Any later mandate, research engagement, license, or capital relationship requires a separate written agreement and its own legal and operational review.

2. Evidence status

Research should identify the status of material evidence rather than collapse every result into the word performance:

  • Research hypothesis: a proposed mechanism or testable claim, not a demonstrated result.
  • Historical observation: a measured relationship in observed data that may be descriptive, selected after inspection, or non-causal.
  • Backtest or simulation: a hypothetical result produced by applying rules, models, or assumptions to historical or generated data; it does not represent actual trading.
  • Paper or forward test: a result observed after model selection without full capital execution; it can still omit fills, financing, operational constraints, and behavioural decisions.
  • Verified actual result: a result supported by relevant account or execution records and described with the period, universe, capital basis, fees, material changes, and verification scope. No public result should be treated as actual merely because it is described as live, tracked, or out-of-sample.

If an article does not expressly identify verified actual results, treat its performance-like output as research evidence rather than a client or investable track record.

3. Hypothetical and backtested results

Hypothetical and backtested results have inherent limitations. They can benefit from hindsight, data mining, multiple testing, researcher degrees of freedom, favourable start or end dates, survivorship bias, look-ahead bias, stale or revised data, universe selection, parameter tuning, and the silent abandonment of failed variants.

Trades were not necessarily executed. A model does not reproduce the effect of rejected orders, partial fills, queue position, latency, discretionary overrides, margin pressure, capital withdrawals, operational incidents, or a decision-maker's ability to continue through losses. Alternative assumptions or equally reasonable implementations can produce materially different results.

No representation is made that an account will achieve a result similar to a model, scenario, forecast, target, or backtest. Past, hypothetical, or simulated results do not guarantee future outcomes.

4. Costs, liquidity, and capacity

A gross research result can change materially after management or incentive fees, commissions, spreads, slippage, borrow cost and availability, financing, funding, taxes, latency, rebalancing, roll mechanics, market impact, and data or infrastructure cost. Unless an article says otherwise, a result should not be assumed to be net of all costs relevant to a particular investor.

Liquidity and capacity are conditional. Market depth can disappear, shorting can become unavailable, a signal can crowd, execution can move the price, and returns can decay as capital scales. An implementation that appears plausible for one capital base, venue, frequency, or period may be unusable for another.

5. Portfolio fit and diversification

Correlation, beta, drawdown overlap, tail dependence, and marginal risk contribution are estimates, not constants. Relationships can converge in stress, change with sizing or leverage, and be dominated by exposures that were weak or absent in the study period.

Diversification is a research objective to be measured under explicit portfolio assumptions; it does not eliminate loss or establish suitability. A low average correlation can coexist with severe joint drawdowns. Portfolio claims require the reader's actual holdings, constraints, liabilities, liquidity needs, governance, and risk budget.

6. Market, instrument, and model risk

Research may concern securities, derivatives, futures, options, currencies, digital assets, rates, volatility, short positions, leverage, or other exposures. Depending on the instrument and implementation, loss can be rapid, exceed posted collateral or model expectations, and be amplified by leverage, gaps, illiquidity, counterparty failure, settlement, basis, concentration, or operational risk.

Models are simplified representations. They can be misspecified, incorrectly coded, calibrated to an obsolete regime, sensitive to data or parameters, or used outside their intended scope. A validation process reduces some avoidable error; it cannot prove permanence or remove market risk.

7. Data, sources, and third parties

Research can depend on public, licensed, vendor, exchange, issuer, academic, or derived data. Sources can be incomplete, delayed, revised, restated, survivorship-affected, incorrectly mapped, or unavailable for reproduction. A citation records the source context known at publication; it is not an endorsement or a guarantee that the source will remain accessible or unchanged.

Third-party names, marks, indices, datasets, and links remain subject to their owners' rights and terms. Unless stated expressly, no third party sponsors, approves, verifies, or endorses PRO QUANT TRADE or a published conclusion.

8. AI and automation

Automated systems may collect sources, run deterministic checks, generate figures, structure analysis, or prepare prose. Published research should identify relevant provenance, and automated drafts remain subject to human publication control. AI output can fabricate facts, citations, code, reasoning, or confidence; human review can also miss error.

A generated figure is evidence only when its inputs, transformation, source, caption, alt text, and readable data fallback are adequate for scrutiny. Editorial refinement must not silently change a thesis, result, citation, limitation, or evidence status.

9. Conflicts and commercial interests

PRO QUANT TRADE may discuss research partnerships, validation work, data or strategy licensing, mandates, or capital relationships through separate private agreements. Those possibilities create commercial interests and do not convert public research into an offer.

Holdings and relationships can change. The absence of a position statement should not be read as a representation that every contributor or related person has no exposure to an instrument discussed. A material position, sponsorship, compensation arrangement, data-provider relationship, or other conflict known to the publication and relevant to the thesis should be stated in the article-specific disclosure.

The site does not claim that a regulator, exchange, data provider, or professional body has approved the publication, its methods, or a result. Regulatory status and prescribed disclosure duties depend on the actual operator, activity, instrument, audience, and jurisdiction, not on this page.

10. Article-specific and prescribed disclosures

Each research article must state its material assumptions, evidence status, methodology, limitations, provenance, source record, and conflicts relevant to interpretation. Where applicable law requires prescribed cautionary language for hypothetical or simulated performance, that language must appear prominently and in immediate proximity to the result. A footer link or this general page is not a substitute.

Before any research is used in regulated marketing, fundraising, personalized advice, a managed account, a fund, a commodity program, or another commercial offering, qualified counsel and the responsible institution must determine the disclosures, books and records, approvals, verification, and performance presentation rules that apply.

11. Corrections and versioning

Research is a dated record, not an immutable claim of truth. Material corrections should identify what changed and when, preserve appropriate provenance, and propagate to the canonical page and machine-readable representations. Withdrawal can be appropriate when evidence, rights, or safety require it.

The publication does not promise that every error will be detected immediately. Readers should use the canonical article, review its modification date and update note, and report a suspected material error through the Contact page.

12. Independent judgment

No research process guarantees accuracy, completeness, timeliness, profitability, robustness, capacity, or diversification. Readers must evaluate suitability and risk independently, test assumptions against their own data and constraints, and obtain professional advice where appropriate.